Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hikma Pharmaceuticals PLC - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
HKMPY
Over the counter
2830
www.hikma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hikma Pharmaceuticals PLC
Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US
- Jul 2nd, 2025 6:00 am
Trending tickers: Palantir, Boeing, UBS, WH Smith and Hikma Pharmaceuticals
- Jun 30th, 2025 3:18 am
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
- Jun 28th, 2025 9:00 am
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
- May 27th, 2025 12:00 am
Growth is what results from strategy. Luckily, this firm has a plan
- May 26th, 2025 10:00 pm
Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 97% Above Its Share Price
- May 16th, 2025 1:30 am
Stocks to watch this week: Tesla, Alphabet, Intel, Boeing and Unilever
- Apr 17th, 2025 11:00 pm
Hikma acquires Novugen's FDA-approved ANDA for trametinib
- Apr 17th, 2025 11:10 am
With 57% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backing
- Apr 12th, 2025 2:45 am
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
- Mar 20th, 2025 6:06 am
Should Income Investors Look At Hikma Pharmaceuticals PLC (LON:HIK) Before Its Ex-Dividend?
- Mar 16th, 2025 2:00 am
AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals
- Mar 6th, 2025 8:27 am
Hikma Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
- Feb 27th, 2025 10:36 pm
Hikma Pharmaceuticals PLC (HKMPF) (Q4 2024) Earnings Call Highlights: Surpassing Revenue ...
- Feb 27th, 2025 12:03 am
Trending tickers: Nvidia, Tesla, Super Micro, AB InBev and BP
- Feb 26th, 2025 4:27 am
Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin
- Feb 21st, 2025 8:09 am
Investing in Hikma Pharmaceuticals (LON:HIK) five years ago would have delivered you a 38% gain
- Feb 11th, 2025 6:34 am
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg
- Jan 14th, 2025 5:41 am
Is Hikma Pharmaceuticals PLC (HIK.L) Among the U.K. Dividend Aristocrats for 2024?
- Dec 29th, 2024 2:27 am
Hikma Pharmaceuticals PLC's (LON:HIK) Stock Is Going Strong: Have Financials A Role To Play?
- Dec 20th, 2024 2:40 am
Scroll